RabMAb

Anti-Human IgG抗体[EPR4421] (ab109489)

发表研究结果有使用 ab109489?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab109489 被引用在 7 文献中.

  • Shiokawa M  et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut N/A:N/A (2016). Human . PubMed: 26964842
  • Zhang L  et al. Novel FOXC2 Mutation in Hereditary Distichiasis Impairs DNA-Binding Activity and Transcriptional Activation. Int J Biol Sci 12:1114-20 (2016). PubMed: 27570485
  • Ma JM  et al. Clinical research on benign lymphoepithelial lesions of lacrimal gland in 20 Chinese patients. Chin Med J (Engl) 128:493-8 (2015). IHC-P ; Human . PubMed: 25673452
  • Graves JD  et al. Apo2L/TRAIL and the death receptor 5 agonist antibody AMG 655 cooperate to promote receptor clustering and antitumor activity. Cancer Cell 26:177-89 (2014). WB ; Human . PubMed: 25043603
  • Kataoka TR  et al. An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall. World J Surg Oncol 12:186 (2014). IHC-P ; Human . PubMed: 24938355
  • Huang SY  et al. Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma. Ann Hematol 93:1371-80 (2014). IHC-P ; Human . PubMed: 24687382
  • Sapra P  et al. Long-term tumor regression induced by an antibody-drug conjugate that targets 5T4, an oncofetal antigen expressed on tumor-initiating cells. Mol Cancer Ther 12:38-47 (2013). IHC-P . PubMed: 23223830

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"